Results 101 to 110 of about 1,281,552 (342)

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Rapid Health Technology Assessment in Rehabilitation Hospital: Review Article

مجله دانشکده پزشکی اصفهان, 2013
Background: Medical advances, improved health status, and increased longevity have led to increased elderly in the society; therefore, the role of rehabilitation centers in the service industry has grown considerably in the two past decades.
Sheila Doaee, Mohamadreza Mobinizadeh, Alireza Oliyaeemanesh   +2 more
doaj  

Coverage and distributional benefit–cost of rotavirus vaccine in Uganda: an analysis of routine health facility aggregated data

Cost Effectiveness and Resource Allocation
Introduction Owing to the lack of local cost and clinical effectiveness data in sub-Saharan Africa, economic evaluations of the rotavirus vaccine are still limited in the region.
Rornald Muhumuza Kananura, Gatien de Broucker, Anthony Ssebagereka, Aloysius Mutebi, Elizabeth Ekirapa Kiracho, Bryan Patenaude   +5 more
doaj   +1 more source

Anemia, costs and mortality in Chronic Obstructive Pulmonary Disease

Cost Effectiveness and Resource Allocation, 2006
Background Little is known about cost implications of anemia and its association with mortality in chronic obstructive pulmonary disease (COPD). This claims analysis addresses these questions. Methods Using the the US Medicare claims database (1997–2001),
Lau Edmund C, Schmier Jordana K, Zilberberg Marya D, Halpern Michael T, Shorr Andrew F   +4 more
doaj   +1 more source

Current trends in single‐cell RNA sequencing applications in diabetes mellitus

FEBS Open Bio, EarlyView.
Single‐cell RNA sequencing is a powerful approach to decipher the cellular and molecular landscape at a single‐cell resolution. The rapid development of this technology has led to a wide range of applications, including the detection of cellular and molecular mechanisms and the identification and introduction of novel potential diagnostic and ...
Seyed Sajjad Zadian, Khodakaram Jahanbin, Shekoofeh Nikooei, Marzieh Rostaminejad, Arezoo Rahimi, Pedram Abdizadeh, Behnam Alipoor   +6 more
wiley   +1 more source

Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR® TS

Diabetes, Metabolic Syndrome and Obesity, 2011
Przemyslaw Holko, Pawal KawalecHTA Centre, Kraków, PolandAims: This study assessed the cost efficacy and cost utility of the automatic blood glucose meter CONTOUR® TS from the public payer (National Health Fund [NHF]) and payer ...
Przemyslaw Holko, Pawal Kawalec
doaj  

Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali

Cost Effectiveness and Resource Allocation, 2009
Background Communicable diseases are the leading causes of illness, deaths, and disability in sub-Saharan Africa. To address these threats, countries within the World Health Organization (WHO) African region adopted a regional strategy called Integrated ...
Touré Kandioura, Sacko Massambou, Mebrahtu Goitom, Abdulmumini Usman, Messonnier Nancy E, Perry Helen N, Meltzer Martin I, Somda Zana C, Ki Salimata, Okorosobo Tuoyo, Alemu Wondimagegnehu, Sow Idrissa   +11 more
doaj   +1 more source

Cost-Effectiveness and Cost-Benefit Analyses for Public Health Programs [PDF]

, 1968
Warren Smith
openalex   +1 more source

Cost-Effectiveness of Renewable Electricity Policies [PDF]

We analyze policies to promote renewable sources of electricity. A renewable portfolio standard raises electricity prices and primarily reduces gas-fired generation. A “knee” of the cost curve exists between 15% and 20% goals for 2020 in our central case,
Burtraw, Dallas, Palmer, Karen
core  

Establishing cost-effectiveness of genetic targeting of cancer therapies [PDF]

, 2011
The clinical benefit of a new genomic instrument, the 70-gene signature for breast cancer patients, is being evaluated in a randomised clinical trial. The early, controlled implementation process is supported by a Constructive Technology Assessment to ...
Harten, W.H. van, Joore, M.A., Retèl, Valesca P., Rutgers, E.J.Th.   +3 more
core   +1 more source